Coenzyme Q10 effects in neurological diseases.

Area of Science:

• Biochemistry
• Cell Biology
• Neuroscience

Background:

• Coenzyme Q10 (CoQ10) is an endogenous lipophilic benzoquinone crucial for cellular respiration and antioxidant defense.
• It is vital for mitochondrial function, membrane integrity, and extramitochondrial electron transport.
• CoQ10 acts as the sole endogenous lipid antioxidant, influencing gene expression and overall metabolism.

Purpose of the Study:

• To review the clinical and experimental effects of CoQ10 supplementation in various neurological diseases.
• To explore CoQ10's role in cardiovascular hypertension due to its central regulatory mechanisms.
• To summarize the safety and tolerability profile of CoQ10 supplementation.

Main Methods:

• Literature review of clinical trials and experimental studies on CoQ10 supplementation.
• Analysis of CoQ10's biochemical and physiological roles in cellular processes.
• Examination of CoQ10's impact on specific neurological conditions and hypertension.

Main Results:

• CoQ10 supplementation is generally safe and well-tolerated, even at high doses.
• Evidence suggests potential therapeutic benefits of CoQ10 in conditions like migraine and hypertension.
• Efficacy in some neurological diseases, such as Parkinson's, is more pronounced in animal models than in human patients.

Conclusions:

• CoQ10 supplementation can be considered as an adjunct therapy in certain neurological diseases and hypertension.
• Further research is needed to clarify the variable efficacy of CoQ10 across different conditions and patient populations.
• Development of novel CoQ10 preparations aims to improve absorption and tissue distribution for enhanced therapeutic outcomes.